Results 11 to 20 of about 3,021 (239)

Transfusion Reactions in Paediatric Patients; Hemovigilance Data from a Tertiary Hospital [PDF]

open access: yesChildren
Objective: This study aimed to define transfusion-related adverse reactions (TRs) observed in paediatric patients at a university hospital in Turkey. Methods: The data from the archive of the Mersin University Hospital Blood Centre, spanning the period ...
Fatma Durak, Özlem Tezol
doaj   +3 more sources

Evolving TRALI risk across apheresis and whole blood platelet products in the United States: An 18-year American Red Cross hemovigilance analysis. [PDF]

open access: yesTransfusion
Transfusion‐related acute lung injury (TRALI) remains a leading cause of transfusion‐associated mortality in the United States. Donor‐based mitigation has reduced TRALI risk from plasma and apheresis platelets, but the residual risk associated with whole‐
Young PP, Singh U, Webb J, Looney MR.
europepmc   +3 more sources

Novel method for trend change detection and hypothesis generation in hemovigilance: A transfusion-related immunomodulation and blood production changes study. [PDF]

open access: yesTransfusion
Immunomodulatory consequences of transfusion, known as transfusion‐related immune modulation (TRIM), impact patients but are not captured by hemovigilance systems.
Ning S   +15 more
europepmc   +3 more sources

An Integrated Review of Pharmacovigilance, Materiovigilance, and Hemovigilance Programs in India: Evolution, Implementation, and Impact on Patient Safety [PDF]

open access: yesBatna Journal of Medical Sciences
The drug development process is complex, with a central focus on ensuring quality, safety, and efficacy. Despite rigorous clinical trials, adverse drug reactions (ADRs) often become apparent only after widespread clinical use, making post-marketing ...
Venkata Naveen kumar PARUCHURI   +5 more
doaj   +2 more sources

The impact of hemovigilance studies on transfusion practices: Single centre experience

open access: yesHitit Medical Journal
Objective: Blood product transfusion is one of the most commonly used medical interventions worldwide. However, transfusion-related adverse events (TRAEs) can cause morbidity and rarely even mortality.
Samet Yaman   +5 more
doaj   +2 more sources

Hemovigilance: a momentous step to blood safety [PDF]

open access: yesInternational Journal of Basic & Clinical Pharmacology, 2022
Hemovigilance is a series of monitoring procedures that cover the entire transfusion chain, from blood and its component collection to recipient follow-up, collecting and collecting information about unexpected or adverse effects resulting from the ...
Gadhade, Jyoti B.   +3 more
core   +3 more sources

Adverse transfusion reactions following transfusion of blood and blood products in a tertiary care hospital: A step toward hemovigilance

open access: yesAsian Journal of Medical Sciences
Background: Transfusion of blood and blood products is a double-edged sword, so it should be used judiciously. The primary aim of the centralized hemovigilance program is to improve transfusion safety.
Mrigen Choudhury   +3 more
doaj   +2 more sources

Hemovigilance: knowledge, attitude and practice among postgraduates and interns of a tertiary care hospital [PDF]

open access: yesInternational Journal of Basic & Clinical Pharmacology, 2023
Background: Adverse reactions due to transfusion of blood and blood products should be reported for the betterment of patients health and to minimize such effects in the future.
D., Meghana   +3 more
core   +3 more sources

Transfusion-associated adverse events incidence and severity after the implementation of an active hemovigilance program with 24 h follow-up. A prospective cohort study [PDF]

open access: yesTransfusion, 2023
Background: Hemovigilance (HV) is usually based on voluntary reports (passive HV). Our aim is to ascertain credible incidence, severity, and mortality of transfusion-associated adverse events (TAAEs) using an active HV program.
Bueno Cabrera, José Luis   +3 more
core   +2 more sources

Blood transfusion reactions and institutional hemovigilance protocols: A 2-year retrospective single center audit

open access: yesInternational Journal of Medicine and Health Development, 2023
Background: Blood transfusion reactions contribute significantly to the morbidity and mortality of both in- and outpatients in hospitals globally. Developing adequate protocols for detecting and reporting this complication is key to attaining global ...
John C Aneke   +8 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy